{"id":"https://openalex.org/W4283016460","doi":"https://doi.org/10.1097/01.mat.0000840828.14837.ae","title":"BIO23: Recent Status of Development of Hb-based Blood Substitute With Pharmacologic Properties of ATP, Adenosine and Reduced Glutathione","display_name":"BIO23: Recent Status of Development of Hb-based Blood Substitute With Pharmacologic Properties of ATP, Adenosine and Reduced Glutathione","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283016460","doi":"https://doi.org/10.1097/01.mat.0000840828.14837.ae"},"language":"en","primary_location":{"id":"doi:10.1097/01.mat.0000840828.14837.ae","doi":"https://doi.org/10.1097/01.mat.0000840828.14837.ae","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.mat.0000840828.14837.ae","pdf_url":null,"source":{"id":"https://openalex.org/S8999885","display_name":"ASAIO Journal","issn_l":"1058-2916","issn":["1058-2916","1538-943X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASAIO Journal","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jan Simoni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Simoni","raw_affiliation_strings":["Texas HemoBioTherapeutics & BioInnovation Center, Lubbock, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas HemoBioTherapeutics & BioInnovation Center, Lubbock, TX, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045165519","display_name":"Paula Simoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12315562","display_name":"Texas Tech University","ror":"https://ror.org/0405mnx93","country_code":"US","type":"education","lineage":["https://openalex.org/I12315562"]},{"id":"https://openalex.org/I4210145403","display_name":"Covenant Health System","ror":"https://ror.org/04q0ja294","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210145403"]},{"id":"https://openalex.org/I926076166","display_name":"Texas Tech University Health Sciences Center","ror":"https://ror.org/033ztpr93","country_code":"US","type":"education","lineage":["https://openalex.org/I926076166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula Simoni","raw_affiliation_strings":["Texas Tech University Health Sciences Center School of Pharmacy & Covenant Health System, Lubbock, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Tech University Health Sciences Center School of Pharmacy & Covenant Health System, Lubbock, TX, United States","institution_ids":["https://openalex.org/I12315562","https://openalex.org/I4210145403","https://openalex.org/I926076166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090220392","display_name":"Joe X. Castillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130040446","display_name":"Universidad Aut\u00f3noma de Guadalajara","ror":"https://ror.org/05ppk0267","country_code":"MX","type":"education","lineage":["https://openalex.org/I130040446"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Joe X. Castillo","raw_affiliation_strings":["Universidad Autonoma de Guadalajara School of Medicine, Zapopan, Jalisco, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Autonoma de Guadalajara School of Medicine, Zapopan, Jalisco, Mexico","institution_ids":["https://openalex.org/I130040446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019935894","display_name":"Donald E. Wesson","orcid":"https://orcid.org/0009-0007-7952-7401","observed_orcids":["https://orcid.org/0009-0007-7952-7401"]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald E. Wesson","raw_affiliation_strings":["Texas A&M University College of Medicine & DE Wesson Consulting, LLC, Dallas, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas A&M University College of Medicine & DE Wesson Consulting, LLC, Dallas, TX, United States","institution_ids":["https://openalex.org/I91045830"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"68","issue":"Supplement 2","first_page":"21","last_page":"21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12094","display_name":"Hemoglobin structure and function","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12094","display_name":"Hemoglobin structure and function","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemoglobin-based-blood-substitutes","display_name":"hemoglobin-based blood substitutes","score":0.8769999742507935},{"id":"https://openalex.org/keywords/artificial-oxygen-carriers","display_name":"artificial oxygen carriers","score":0.7289999723434448},{"id":"https://openalex.org/keywords/reduced-glutathione","display_name":"reduced glutathione","score":0.9660000205039978},{"id":"https://openalex.org/keywords/bovine-hemoglobin","display_name":"bovine hemoglobin","score":0.8500000238418579},{"id":"https://openalex.org/keywords/hemoglobin-toxicity","display_name":"hemoglobin toxicity","score":0.675000011920929},{"id":"https://openalex.org/keywords/endotoxin-clearance","display_name":"endotoxin clearance","score":0.6349999904632568},{"id":"https://openalex.org/keywords/virus-inactivation","display_name":"virus inactivation","score":0.6069999933242798},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.8949999809265137},{"id":"https://openalex.org/keywords/vasodilation","display_name":"vasodilation","score":0.7269999980926514},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.7440000176429749},{"id":"https://openalex.org/keywords/blood-shortage","display_name":"blood shortage","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5745185613632202},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.5687669515609741},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5413681268692017},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.47264164686203003},{"id":"https://openalex.org/C2776557347","wikidata":"https://www.wikidata.org/wiki/Q37187","display_name":"Red blood cell","level":2,"score":0.42249301075935364},{"id":"https://openalex.org/C2778337571","wikidata":"https://www.wikidata.org/wiki/Q831050","display_name":"Blood substitute","level":3,"score":0.42035675048828125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4202975034713745},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41505166888237},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41327041387557983},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3165366053581238},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16537317633628845},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.mat.0000840828.14837.ae","doi":"https://doi.org/10.1097/01.mat.0000840828.14837.ae","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.mat.0000840828.14837.ae","pdf_url":null,"source":{"id":"https://openalex.org/S8999885","display_name":"ASAIO Journal","issn_l":"1058-2916","issn":["1058-2916","1538-943X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASAIO Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4290465689","https://openalex.org/W1262376714","https://openalex.org/W1880966051","https://openalex.org/W2151470584","https://openalex.org/W2232750936","https://openalex.org/W3160160389","https://openalex.org/W1493494314","https://openalex.org/W3151264986","https://openalex.org/W2043968509","https://openalex.org/W1987602110"],"abstract_inverted_index":{"Background:":[0],"SARS-CoV-2":[1],"pandemic":[2],"brought":[3],"new":[4,218],"attention":[5],"to":[6,22,56,269],"blood":[7,27,38,50,81,103,273],"substitutes":[8,51,82],"as":[9,181,240],"a":[10,36,91,99,132,182,241],"potential":[11],"remedy":[12],"for":[13,25,138,275],"treatment":[14],"of":[15,47,80,87,94,110,141,221,228],"COVID-19":[16],"associated":[17],"hypoxemia":[18],"and":[19,97,101,118,122,144,146,157,163,196,213,224,230,238,251,260,263],"more":[20,72],"importantly":[21],"provide":[23],"relief":[24],"sagging":[26],"banks.":[28],"In":[29],"fact":[30],"the":[31,40,62,77],"American":[32],"Red":[33],"Cross":[34],"declared":[35],"national":[37],"crisis,":[39],"worst":[41],"in":[42,171,188],"decades.":[43],"Although":[44],"commercialization":[45],"attempts":[46],"1st":[48],"generation":[49],"have":[52,152],"been":[53,153],"unsuccessful":[54],"due":[55],"toxicity":[57,86,212],"and/or":[58],"poor":[59],"efficacy":[60,164],"problems,":[61],"artificial":[63],"oxygen":[64,243],"carriers\u2019":[65],"field":[66],"is":[67,179,236,249],"rapidly":[68],"expanding":[69],"again":[70],"creating":[71],"innovative":[73],"products.":[74],"To":[75],"attenuate":[76],"adverse":[78],"effects":[79],"caused":[83],"by":[84],"intrinsic":[85,211],"Hb":[88,113,186,205,215],"we":[89],"implemented":[90],"novel":[92],"concept":[93],"\u2018pharmacologic":[95,199],"cross-linking\u2019":[96,200],"formulated":[98,180],"safe":[100],"effective":[102,139,272],"substitute":[104,274],"-":[105],"HemoTech.":[106],"Methods:":[107],"HemoTech":[108,128,178,235,267],"consists":[109],"pure":[111],"bovine":[112],"cross-linked":[114],"intramolecularly":[115],"with":[116,120,124,173,194,204,217,245],"o-ATP":[117],"intermolecularly":[119],"oadenosine":[121],"conjugated":[123],"reduced":[125],"glutathione":[126],"(GSH).":[127],"cGMP":[129],"manufacturing":[130],"includes":[131],"novel,":[133],"validated":[134],"orthogonal":[135],"technology":[136],"platform":[137],"clearance":[140],"endotoxin,":[142],"prions":[143],"non-enveloped":[145],"enveloped":[147],"viruses.":[148],"Regulatory":[149],"mandated":[150],"requirements":[151],"met":[154],"including":[155],"CMC":[156],"GLP":[158],"non-clinical":[159],"pharmacology,":[160],"toxicology,":[161],"genotoxicity":[162],"studies.":[165],"HemoTech\u2019s":[166],"clinical":[167,231,277],"\u2018proof-of-concept\u2019":[168],"was":[169],"performed":[170],"children":[172],"sickle":[174],"cell":[175],"anemia.":[176],"Results:":[177],"6.5":[183],"g/dL":[184],"modified":[185],"solution":[187],"oxy-":[189],"or":[190],"carbon":[191],"monoxy-form,":[192],"enriched":[193],"electrolytes":[195],"mannitol.":[197],"The":[198,226],"does":[201],"not":[202],"interfere":[203],"respiratory":[206],"function,":[207],"but":[208],"eradicates":[209],"Hb\u2019s":[210],"provides":[214],"molecules":[216],"medicinal":[219],"properties":[220],"ATP,":[222],"adenosine":[223],"GSH.":[225],"results":[227],"preclinical":[229],"studies":[232],"indicate":[233],"that":[234,255],"non-toxic":[237],"works":[239],"physiological":[242],"carrier":[244],"prolonged":[246],"intravascular":[247],"persistence,":[248],"vasodilatory":[250],"can":[252],"reduce":[253],"vasoconstriction":[254],"follows":[256],"hemorrhage,":[257],"has":[258],"antioxidant":[259],"anti-inflammatory":[261],"activities,":[262],"erythropoietic":[264],"properties.":[265],"Conclusion:":[266],"promises":[268],"be":[270],"an":[271],"various":[276],"indications.":[278]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2022-06-18T00:00:00"}